We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 143 → 0 (-143)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $1.61B → $0 (-$1.61B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
–
Holders Change
-143
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$119M
2
PAI
Palo Alto Investors
California
-$84.4M
3
GF
Gabelli Funds
New York
-$80.2M
4
AA
AQR Arbitrage
Connecticut
-$74.8M
5
BFA
BlackRock Fund Advisors
California
-$72.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
– -$18.6M -251,154 Closed
CCM
27
Chicago Capital Management
Illinois
– -$17.1M -228,196 Closed
KPF
28
K2 Principal Fund
Ontario, Canada
– -$17.1M -227,992 Closed
OAC
29
OMERS Administration Corp
Ontario, Canada
– -$16.6M -221,500 Closed
FNYS
30
First New York Securities
New York
– -$15.5M -206,109 Closed
TS
31
Twin Securities
New York
– -$14.4M -191,792 Closed
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
– -$14.4M -191,753 Closed
RC
33
RegentAtlantic Capital
New Jersey
– -$12M -160,181 Closed
LIM
34
Longfellow Investment Management
Massachusetts
– -$11.3M -150,321 Closed
CC
35
Carlson Capital
Texas
– -$11.2M -150,000 Closed
CS
36
Credit Suisse
Switzerland
– -$11.1M -147,892 Closed
Geode Capital Management
37
Geode Capital Management
Massachusetts
– -$10.1M -135,076 Closed
BPGAM
38
BTG Pactual Global Asset Management
Bermuda
– -$10M -133,358 Closed
TAM
39
Tocqueville Asset Management
New York
– -$8.99M -119,912 Closed
Allianz Asset Management
40
Allianz Asset Management
Germany
– -$8.96M -119,475 Closed
HM
41
Harvest Management
New York
– -$8.54M -113,923 Closed
SCM
42
Stevens Capital Management
Pennsylvania
– -$8.54M -113,907 Closed
AIMCA
43
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$8.5M -113,400 Closed
AAM
44
Aureus Asset Management
Massachusetts
– -$8.45M -112,702 Closed
CC
45
Coastland Capital
California
– -$8.36M -111,499 Closed
PCM
46
Prelude Capital Management
New York
– -$8.24M -109,923 Closed
Bank of New York Mellon
47
Bank of New York Mellon
New York
– -$7.77M -103,636 Closed
COPPSERS
48
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$6.94M -92,593 Closed
BIM
49
BlackRock Investment Management
Delaware
– -$6.47M -86,326 Closed
GH
50
GAM Holding
Switzerland
– -$6.25M -83,300 Closed
1
2
3 4 5

KYTH Hedge Fund Activity: Q4 2015 in Review

0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2015, worth a combined $0 — down 100% from $1.61B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of KYTH and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jennison Associates, exiting entirely with an estimated $119M sold.

  • 0 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2015, down from 143 in Q3 2015.
  • Funds reported $0 of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2015, down 100% quarter-over-quarter.
  • 0 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2015 and 142 closed out, a net change of -142 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2015 was Jennison Associates, an estimated $119M sold.

Based on aggregated 13F filings for Q4 2015.